-DOCSTART- -X- O
Many -X- _ O
countries -X- _ O
are -X- _ O
stockpiling -X- _ O
face -X- _ B-Intervention
masks -X- _ I-Intervention
for -X- _ O
use -X- _ O
as -X- _ O
a -X- _ O
nonpharmaceutical -X- _ O
intervention -X- _ O
to -X- _ O
control -X- _ B-Outcome
virus -X- _ I-Outcome
transmission -X- _ I-Outcome
during -X- _ O
an -X- _ O
influenza -X- _ B-Patient
pandemic. -X- _ O
We -X- _ O
conducted -X- _ O
a -X- _ O
prospective -X- _ O
cluster-randomized -X- _ O
trial -X- _ O
comparing -X- _ O
surgical -X- _ B-Intervention
masks -X- _ I-Intervention
, -X- _ I-Intervention
nonâ€“fit-tested -X- _ I-Intervention
P2 -X- _ I-Intervention
masks -X- _ I-Intervention
, -X- _ O
and -X- _ O
no -X- _ B-Comparison
masks -X- _ I-Comparison
in -X- _ O
prevention -X- _ B-Patient
of -X- _ I-Patient
influenza- -X- _ I-Patient
like -X- _ I-Patient
illness -X- _ I-Patient
( -X- _ I-Patient
ILI -X- _ I-Patient
) -X- _ I-Patient
in -X- _ I-Patient
households. -X- _ I-Patient
Mask -X- _ B-Intervention
use -X- _ I-Intervention
adherence -X- _ O
was -X- _ O
self-reported. -X- _ O
During -X- _ O
the -X- _ O
2006 -X- _ O
and -X- _ O
2007 -X- _ O
winter -X- _ O
seasons -X- _ O
, -X- _ O
286 -X- _ O
exposed -X- _ B-Patient
adults -X- _ I-Patient
from -X- _ O
143 -X- _ O
households -X- _ O
who -X- _ O
had -X- _ O
been -X- _ O
exposed -X- _ O
to -X- _ O
a -X- _ O
child -X- _ O
with -X- _ O
clinical -X- _ O
respiratory -X- _ O
illness -X- _ O
were -X- _ O
recruited. -X- _ O
We -X- _ O
found -X- _ O
that -X- _ O
adherence -X- _ B-Outcome
to -X- _ I-Outcome
mask -X- _ I-Outcome
use -X- _ I-Outcome
significantly -X- _ I-Outcome
reduced -X- _ I-Outcome
the -X- _ I-Outcome
risk -X- _ I-Outcome
for -X- _ I-Outcome
ILI-associated -X- _ I-Outcome
infection -X- _ I-Outcome
, -X- _ O
but -X- _ O
< -X- _ O
50 -X- _ O
% -X- _ O
of -X- _ O
participants -X- _ O
wore -X- _ O
masks -X- _ O
most -X- _ O
of -X- _ O
the -X- _ O
time. -X- _ O
We -X- _ O
concluded -X- _ O
that -X- _ O
household -X- _ B-Outcome
use -X- _ I-Outcome
of -X- _ I-Outcome
face -X- _ I-Outcome
masks -X- _ I-Outcome
is -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
low -X- _ I-Outcome
adherence -X- _ I-Outcome
and -X- _ I-Outcome
is -X- _ I-Outcome
ineffective -X- _ I-Outcome
for -X- _ I-Outcome
controlling -X- _ I-Outcome
seasonal -X- _ I-Outcome
respiratory -X- _ I-Outcome
disease. -X- _ I-Outcome
However -X- _ O
, -X- _ O
during -X- _ O
a -X- _ O
severe -X- _ O
pandemic -X- _ O
when -X- _ O
use -X- _ O
of -X- _ O
face -X- _ O
masks -X- _ O
might -X- _ O
be -X- _ O
greater -X- _ O
, -X- _ O
pandemic -X- _ O
transmission -X- _ O
in -X- _ O
households -X- _ O
could -X- _ O
be -X- _ O
reduced -X- _ O
. -X- _ O

